National Health Investors
236 hedge funds and large institutions have $2.43B invested in National Health Investors in 2019 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 110 increasing their positions, 57 reducing their positions, and 28 closing their positions.
93% more repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 57
1% more capital invested
Capital invested by funds: $2.4B → $2.43B (+$24.3M)
0.14% more ownership
Funds ownership: 71.11% → 71.25% (+0.14%)
4% less funds holding
Funds holding: 245 → 236 (-9)
18% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 28
73% less call options, than puts
Call options by funds: $7.91M | Put options by funds: $29.6M
Top Buyers
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$42.7M |
| 2 |
State Street
Boston,
Massachusetts
|
+$15.1M |
| 3 |
HCM
Hamlin Capital Management
New York
|
+$13.8M |
| 4 |
JP Morgan Chase
New York
|
+$11.6M |
| 5 |
Millennium Management
New York
|
+$10.3M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$96M |
| 2 |
BlackRock
New York
|
-$16.6M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10.1M |
| 4 |
Renaissance Technologies
New York
|
-$9.23M |
| 5 |
Citigroup
New York
|
-$9.19M |
NHI Hedge Fund Activity: Q2 2019 in Review
236 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in National Health Investors (NHI) for Q2 2019, worth a combined $2.43B — up 1% from $2.4B a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of NHI and 23 opened new positions — a net loss of 5 holders — while 57 trimmed existing stakes and 110 added.
The largest buyer was Nuveen, adding an estimated $42.7M. The largest seller was Invesco, cutting an estimated $96M.
- 236 institutional investors held National Health Investors (NHI) as of Q2 2019, down from 245 in Q1 2019.
- Funds reported $2.43B of National Health Investors stock for Q2 2019, up 1% quarter-over-quarter.
- 23 funds opened new National Health Investors positions in Q2 2019 and 28 closed out, a net change of -5 holders.
- The largest National Health Investors buyer in Q2 2019 was Nuveen, an estimated $42.7M added.
- The largest National Health Investors seller in Q2 2019 was Invesco, an estimated $96M sold.
Based on aggregated 13F filings for Q2 2019.